The PROPEL sinus implants are intended to maintain patency and locally deliver steroids to the sinus mucosa in patients ≥18 years of age following sinus surgery. PROPEL represents a medical breakthrough clinically proven to improve surgical outcomes for chronic sinusitis sufferers.
PROPEL is the first and only device clinically shown to keep the sinuses open after surgery, precisely deliver anti-inflammatory medication directly into the healing tissues, and then dissolve.
The innovative sinus stent decreases post-operative scarring and inflammation, reducing the need for additional surgical procedures as well as oral steroids1 and their potential side effects. At the same time, PROPEL’s spring-like, lightweight design means patients usually cannot even tell that it is there.
The videos below reflects individual responses to the PROPEL sinus stent. The accounts given are genuine and documented. Each video represents a unique individual experience and does not provide any warranty or guarantee as to the response other people may have to PROPEL.
